Company record
Intas Pharmaceuticals Limited
3 FDA warning letters since 2023 and 0 recalls in the last 12 months.
Get an email the day FDA posts anything new about Intas Pharmaceuticals Limited.
Warning letters
-
DrugsIntas Pharmaceuticals Limited
FDA warns Intas Pharmaceuticals' Dehradun, India plant over weak out-of-spec investigations and untracked batch-record edits for its tablets.
High risk -
DrugsIntas Pharmaceuticals Limited
CGMP/Finished Pharmaceuticals/Adulterated
-
DrugsIntas Pharmaceuticals Limited
CGMP/Finished Pharmaceuticals/Adulterated